First intra-nasal COVID-19 vaccine, a glorious tribute to the call for Atmanirbhar Bharat: Mandaviya https://ift.tt/mLhDlWS

The roll out of iNCOVACC, the first intranasal COVID-19 vaccine that does not require syringes, needles, alcohol wipes, bandages, etc., is expected to begin in private hospitals that have placed advance orders. Initial manufacturing capacity of several million doses per annum has been established; this can be scaled up to a billion doses as required. The Government of India and several state governments have procured iNCOVACC in large volumes at a price of Rs 325 per dose and priced at Rs 800 for private markets, is now available on CoWIN.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/2Hv5t3E